482 related articles for article (PubMed ID: 28178892)
1. Trends in the incidence of AIDS-defining and non-AIDS-defining cancers in people living with AIDS: a population-based study from São Paulo, Brazil.
Tanaka LF; Latorre MDRD; Gutierrez EB; Heumann C; Herbinger KH; Froeschl G
Int J STD AIDS; 2017 Oct; 28(12):1190-1198. PubMed ID: 28178892
[TBL] [Abstract][Full Text] [Related]
2. Incidence of AIDS-defining cancers and virus-related and non-virus-related non-AIDS-defining cancers among HIV-infected patients compared with the general population in a large health district of Northern Italy, 1999-2009.
Calabresi A; Ferraresi A; Festa A; Scarcella C; Donato F; Vassallo F; Limina R; Castelli F; Quiros-Roldan E;
HIV Med; 2013 Sep; 14(8):481-90. PubMed ID: 23560682
[TBL] [Abstract][Full Text] [Related]
3. Trends in Malignancies among Korean Patients Infected with Human Immunodeficiency Virus in the Highly Active Antiretroviral Therapy Era.
Lee S; Lee SH; Lee JE; Kang JS; Lee SG; Chung JS; Kwak IS
J Korean Med Sci; 2017 Sep; 32(9):1445-1450. PubMed ID: 28776339
[TBL] [Abstract][Full Text] [Related]
4. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.
Clifford GM; Polesel J; Rickenbach M; Dal Maso L; Keiser O; Kofler A; Rapiti E; Levi F; Jundt G; Fisch T; Bordoni A; De Weck D; Franceschi S;
J Natl Cancer Inst; 2005 Mar; 97(6):425-32. PubMed ID: 15770006
[TBL] [Abstract][Full Text] [Related]
5. Cancer risk in HIV-infected people in the USA from 1996 to 2012: a population-based, registry-linkage study.
Hernández-Ramírez RU; Shiels MS; Dubrow R; Engels EA
Lancet HIV; 2017 Nov; 4(11):e495-e504. PubMed ID: 28803888
[TBL] [Abstract][Full Text] [Related]
6. Cancer risk in people infected with human immunodeficiency virus in the United States.
Engels EA; Biggar RJ; Hall HI; Cross H; Crutchfield A; Finch JL; Grigg R; Hylton T; Pawlish KS; McNeel TS; Goedert JJ
Int J Cancer; 2008 Jul; 123(1):187-94. PubMed ID: 18435450
[TBL] [Abstract][Full Text] [Related]
7. Incidence of first and second primary cancers diagnosed among people with HIV, 1985-2013: a population-based, registry linkage study.
Hessol NA; Whittemore H; Vittinghoff E; Hsu LC; Ma D; Scheer S; Schwarcz SK
Lancet HIV; 2018 Nov; 5(11):e647-e655. PubMed ID: 30245004
[TBL] [Abstract][Full Text] [Related]
8. Trends in cancer diagnoses and survival among persons with AIDS in a high HIV prevalence urban area.
Castel AD; Young H; Akiwumi AM; Vargas A; Rogers K; West T; Levine PH
AIDS Care; 2015; 27(7):860-9. PubMed ID: 25714364
[TBL] [Abstract][Full Text] [Related]
9. [Malignancy cases in HIV-positive patients in Lodz region in years 1992-2010].
Jabłonowska E; Małolepsza E; Strycharz M; Wójcik K
Przegl Epidemiol; 2011; 65(2):339-43. PubMed ID: 21913486
[TBL] [Abstract][Full Text] [Related]
10. The impact of highly active antiretroviral therapy on the incidence and outcomes of AIDS-defining cancers in Southern Alberta.
Gingues S; Gill MJ
HIV Med; 2006 Sep; 7(6):369-77. PubMed ID: 16903981
[TBL] [Abstract][Full Text] [Related]
11. Epidemiologic contributions to recent cancer trends among HIV-infected people in the United States.
Robbins HA; Shiels MS; Pfeiffer RM; Engels EA
AIDS; 2014 Mar; 28(6):881-90. PubMed ID: 24300545
[TBL] [Abstract][Full Text] [Related]
12. Time trends in cancer incidence in Australian people living with HIV between 1982 and 2012.
Wong IKJ; Grulich AE; Poynten IM; Polizzotto MN; van Leeuwen MT; Amin J; McGregor S; Law M; Templeton DJ; Vajdic CM; Jin F
HIV Med; 2022 Feb; 23(2):134-145. PubMed ID: 34585487
[TBL] [Abstract][Full Text] [Related]
13. The pattern of secondary cancers in patients with Kaposi sarcoma in the United States.
Kumar V; Garg M; Chaudhary N; Soni P; Floudas CS; Nwanyanwu C; Chandra A
Cancer Causes Control; 2017 Oct; 28(10):1065-1074. PubMed ID: 28900786
[TBL] [Abstract][Full Text] [Related]
14. Cancer burden in the HIV-infected population in the United States.
Shiels MS; Pfeiffer RM; Gail MH; Hall HI; Li J; Chaturvedi AK; Bhatia K; Uldrick TS; Yarchoan R; Goedert JJ; Engels EA
J Natl Cancer Inst; 2011 May; 103(9):753-62. PubMed ID: 21483021
[TBL] [Abstract][Full Text] [Related]
15. Assessing the impact of HAART on the incidence of defining and non-defining AIDS cancers among patients with HIV/AIDS: a systematic review.
Cobucci RN; Lima PH; de Souza PC; Costa VV; Cornetta Mda C; Fernandes JV; Gonçalves AK
J Infect Public Health; 2015; 8(1):1-10. PubMed ID: 25294086
[TBL] [Abstract][Full Text] [Related]
16. Risk for cancer among people living with AIDS, 1997-2012: the São Paulo AIDS-cancer linkage study.
Tanaka LF; Latorre MRDO; Gutierrez EB; Curado MP; Froeschl G; Heumann C; Herbinger KH
Eur J Cancer Prev; 2018 Jul; 27(4):411-417. PubMed ID: 28059857
[TBL] [Abstract][Full Text] [Related]
17. [Epidemiology of HIV-associated malignancies].
Launay O; Guillevin L
Bull Cancer; 2003 May; 90(5):387-92. PubMed ID: 12850760
[TBL] [Abstract][Full Text] [Related]
18. Non-AIDS-defining cancers among HIV-infected people.
Pinzone MR; Fiorica F; Di Rosa M; Malaguarnera G; Malaguarnera L; Cacopardo B; Zanghì G; Nunnari G
Eur Rev Med Pharmacol Sci; 2012 Oct; 16(10):1377-88. PubMed ID: 23104654
[TBL] [Abstract][Full Text] [Related]
19. Cumulative incidence of cancer among individuals with acquired immunodeficiency syndrome in the United States.
Simard EP; Pfeiffer RM; Engels EA
Cancer; 2011 Mar; 117(5):1089-96. PubMed ID: 20960504
[TBL] [Abstract][Full Text] [Related]
20. Trends and risk of lung cancer among people living with HIV in the USA: a population-based registry linkage study.
Haas CB; Engels EA; Horner MJ; Freedman ND; Luo Q; Gershman S; Qiao B; Pfeiffer RM; Shiels MS
Lancet HIV; 2022 Oct; 9(10):e700-e708. PubMed ID: 36179753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
